Photo by niaid from unsplash
Limited published research is available on the impact of elexacaftor/tezacaftor/ivacaftor (ETI) beyond the initial few months postdrug initiation, especially for those who initiated therapy via individual investigational new drug application.… Click to show full abstract
Limited published research is available on the impact of elexacaftor/tezacaftor/ivacaftor (ETI) beyond the initial few months postdrug initiation, especially for those who initiated therapy via individual investigational new drug application. The experiences of patients with cystic fibrosis (CF) experiencing severe lung disease were reviewed for significant improvements in clinical symptoms and quality of life.
Keywords:
cystic fibrosis;
elexacaftor tezacaftor;
tezacaftor ivacaftor
Journal Title: Pediatric Pulmonology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatric Pulmonology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!